Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026

The Quick Take
Company to hold a conference call at 8AM ET on November 5, 2026 to review results and provide a corporate update SHELTON, Conn., Oct. 30, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Buyers Edge Platform Names Sam Peterson Chief Technology Officer to Accelerate AI-Driven Innovation
WALTHAM, Mass., Oct. 30, 2026 /PRNewswire/ -- Buyers Edge Platform (BEP), a leading digital procurement network and solutions provider for the foodservice…
Business
Kuvings Introduces AUTO10 SQUARE™ Plus, Bringing Effortless Hands-Free Juicing to Modern Kitchens
Advanced cold-press technology meets space-saving design with expandable capacity for healthier living. CHICAGO, Oct. 30, 2026 /PRNewswire/ -- Kuvings, a…
Business
Apollo Rider Data Shows Electric Scooters Lose About 12% of Range at Freezing, Not the 20 to 50% Often Cited
512,359 real-world rides show the loss is gradual and reversed by spring. A second study finds no measurable battery range loss through 2,500 miles. MONTREAL,…
Business
Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.
PITTSBURGH, Oct. 30, 2026 /PRNewswire/ -- Viatris Inc. ("Viatris") (Nasdaq: VTRS), a global healthcare company, today announced that Peach Purchaser Sub Inc.…
